Dr. Rushang Patel earned his medical degree from Maharaja Sayajirao University in India. His strong interest in cancer research brought him to the US for a PhD. He conducted his research on understanding how toxic chemicals, like dioxin (agent orange), cigarette smoke, etc. cause cancer. He identified a previously unknown mechanism of controlling important proteins in the cells that are involved in various human diseases like gout, arthritis, high cholesterol and even cancer. As a result of his research, a novel group of compounds has been discovered which are being tested for their medicinal effect. He has presented his research findings at multiple international meetings.
After completing his PhD, he pursued training in internal medicine followed by a fellowship in hematology and oncology at Fox Chase Cancer Center, one of the twenty-one centers recognized as National Comprehensive Cancer centers in the country. He recently authored a book chapter on stem cell transplant for hematologic malignancies. In addition he has multiple original research articles published in peer-reviewed journals. His articles have been cited over 300 times by other researchers.
Dr. Patel has received numerous awards throughout his career, including a scholarship for top rank in medical school, research excellence award from the American Society of Toxicology, best intern, best resident and the Frobese scholar award. Dr. Patel has been awarded the fellowship to American College of Physicians, a prestigious acknowledgement that is often presented to senior physicians. He also holds membership of the American Society of Hematology, American Society of Bone Marrow Transplantation and American Society of Clinical Oncology. Dr. Patel has been an ad hoc reviewer for multiple medical journals, including the British Journal of Hematology. In addition to English, he speaks fluent Hindi and Gujarati.
Dr. Patel's clinical and research interests include managing patients with high risk lymphoma and performing haploidentical transplants. During his fellowship, he trained with Dr. Richard Fisher, a world renowned expert in lymphoma. Haploidentical transplant is a recent advancement that provides the option of stem cell transplant even to patients who do not have a fully matched donor. Dr. Patel is also interested in conducting research in graft engineering wherby the adverse effects associated with stem cell transplant can be minimized while enhancing its anti-tumor effect.